Position in CCCC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,355,354
+$712,301 QoQ
Shares Held
290,226
+18.7% QoQ
Ownership
0.236%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 147 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in CCCC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,026 across 296 Biotechnology names. CCCC ranks #133 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in CCCC
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,355,354 | 290,226 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $643,053 | 244,507 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $512,548 | 268,350 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $425,840 | 191,820 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $221,674 | 155,017 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $223,176 | 139,486 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $249,094 | 69,193 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $367,911 | 64,546 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $302,605 | 65,499 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $314,839 | 38,536 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,910,263 | 692,082 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $104,887 | 56,391 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $153,752 | 55,910 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $218,100 | 69,459 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $95,733 | 16,226 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $142,564 | 16,256 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $104,465 | 13,855 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,357,872 | 138,412 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $14,947,302 | 464,202 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $21,022,966 | 470,523 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $17,761,904 | 469,395 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $22,553,504 | 609,719 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $9,956,954 | 300,542 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||